François-Xavier Gros

13PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursGene and molecular therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 21, 2026
Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.

|Jan 09, 2026
Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma.

Emilie Charton, Amélie Anota, Emmanuel Bachy

|Oct 22, 2025
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.

Federico Erbella, Emmanuel Bachy, Guillaume Cartron

|May 01, 2025
TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas.

Pierre Stephan, Roberta Di Blasi, Louise Roulin

|Apr 03, 2025
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study.

Guillaume Cartron, Roch Houot, Yassine Al Tabaa

|Jan 28, 2025
Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study.

Xavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros

Pageof 3

Frequent Collaborators

12 joint publications

Emmanuel Bachy

10 joint publications

Roch Houot

9 joint publications

Sylvain Choquet

5 joint publications

Fabrice Jardin